Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06342414 · ClinicalTrials.gov registry record
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
A clinical trial of Hepatocellular Carcinoma and Cholangiocarcinoma, sponsored by City of Hope Medical Center.
- Recruiting
- Registry status
- 400
- Enrollment target
- 5
- Study locations
NCT06342414 is a study of Hepatocellular Carcinoma and Cholangiocarcinoma that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 400 participants, above the 255-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (57% higher). The trial reports 5 study locations across 2 states.
The verdict
NCT06342414, a study of Hepatocellular Carcinoma and Cholangiocarcinoma, is actively recruiting participants, sponsored by City of Hope Medical Center.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 5
- Study locations
Study Summary
It is sometimes difficult to precisely understand whether a primary liver cancer is a hepatocellular carcinoma or a cholangiocarcinoma. The researchers will develop and validate a liquid biopsy, based on exosomal content analysis and powered by machine learning, to help clinicians differentiate these two cancers before surgery.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST ELUCIDATE
Study Locations (5)
Other
- Graduate School of Medical Sciences, Kyushu University - Fukuoka
- Graduate School of Medical Sciences, Kumamoto University - Kumamoto
- Hokkaido University Graduate School of Medicine - Sapporo
- Tokushima University - Tokushima
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-03-15 |
| Est. Completion | 2026-06-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06342414
The ClinicalTrials.gov registry entry for NCT06342414 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 255-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (57% higher). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Hepatocellular Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which ELUCIDATE is the first listed.
NCT06342414 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Other, California.
Frequently Asked Questions
What is clinical trial NCT06342414 about?
NCT06342414 is a clinical study titled "An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer". It is sometimes difficult to precisely understand whether a primary liver cancer is a hepatocellular carcinoma or a cholangiocarcinoma. The researchers will develop and validate a liquid biopsy, based on exosomal content analysis and powered by machine learning, to help clinicians differentiate thes...
What is the current status of trial NCT06342414?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2024-03-15. Estimated completion is 2026-06-18.
What conditions does trial NCT06342414 study?
This clinical trial studies the following conditions: Hepatocellular Carcinoma, Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Hepatic Cancer, Primary Liver Cancer.
What interventions are being tested in trial NCT06342414?
The interventions under investigation include: ELUCIDATE (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06342414?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06342414 being conducted?
This trial has 5 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatocellular Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Molecular Basis of Pediatric Liver Cancer
RECRUITING
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Targeted Navigation in Hepatocellular Carcinoma (HCC)
RECRUITING · NA
-
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RECRUITING · Phase 1
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.